SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid Cardiomyopathy
18:56
Prognostic mortality factors in advanced light chain cardiac amyloidosis A prospective cohort study
20:28
Premier retour sur HELIOS B suite a l ESC Vutrisiran in Patients with Transthyretin Amyloidosis wit
56:47
[WEBINAIRE ISQ Certification] Retrospective 2024 & perspectives 2025
21:29
Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac
1:01:34
Webinaire Sefam #3 : Suivi clinique et Outcomes du Traitement par PPC
1:07:57
02 Session 2
16:34
Deep Learning Enabled Quantification of 99mTc Pyrophosphate SPECT CT for Cardiac Amyloidosis
18:17